Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

EBF2 Inhibitors

EBF2 inhibitors are a class of chemical compounds that specifically target and inhibit the function of the EBF2 protein, a member of the Early B-cell Factor (EBF) family of transcription factors. The EBF family is known for its pivotal role in regulating gene expression, particularly during the development and differentiation of various cell types, including those in the nervous and immune systems. EBF2, in particular, has been implicated in the regulation of processes such as adipogenesis, neuronal development, and the differentiation of certain immune cells. As a transcription factor, EBF2 binds to specific DNA sequences, modulating the transcription of genes that are critical for maintaining cellular identity and promoting the differentiation of precursor cells into their specialized forms. The inhibition of EBF2 by specific inhibitors typically involves the binding of these compounds to key functional domains of the EBF2 protein, such as its DNA-binding domain or regions involved in protein-protein interactions. This binding prevents EBF2 from effectively binding to its target DNA sequences or from interacting with other transcriptional co-regulators, thereby disrupting its ability to regulate the expression of target genes. As a result, inhibiting EBF2 can lead to a cascade of effects within the cell, including altered gene expression patterns, disruptions in cellular differentiation pathways, and potential impacts on cellular development and function. Furthermore, EBF2 inhibitors may interfere with the formation and stability of transcriptional complexes that rely on EBF2, thereby affecting broader regulatory networks within the cell. By studying the effects of EBF2 inhibition, researchers can gain deeper insights into the specific roles this transcription factor plays in various biological processes, contributing to a more comprehensive understanding of the molecular mechanisms that govern gene expression, cell differentiation, and the maintenance of cellular identity across different tissues and developmental stages.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

Might demethylate DNA, potentially affecting the transcription of genes including EBF2.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

Could affect DNA methylation, possibly influencing EBF2 gene expression.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$131.00
$515.00
2
(1)

May inhibit DNA methyltransferases, potentially impacting EBF2 expression.

Zebularine

3690-10-6sc-203315
sc-203315A
sc-203315B
10 mg
25 mg
100 mg
$129.00
$284.00
$1004.00
3
(1)

Could inhibit DNA methylation, possibly affecting EBF2 gene expression.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Might increase histone acetylation, potentially influencing EBF2 transcription.

Belinostat

414864-00-9sc-269851
sc-269851A
10 mg
100 mg
$156.00
$572.00
(1)

Could affect histone modification, potentially impacting EBF2 gene expression.

Panobinostat

404950-80-7sc-208148
10 mg
$200.00
9
(1)

May modulate histone acetylation, potentially affecting EBF2 expression.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Might inhibit histone deacetylases, potentially influencing EBF2 transcription.

Romidepsin

128517-07-7sc-364603
sc-364603A
1 mg
5 mg
$218.00
$634.00
1
(1)

Could inhibit histone deacetylation, potentially impacting EBF2 expression.

MS-275

209783-80-2sc-279455
sc-279455A
sc-279455B
1 mg
5 mg
25 mg
$24.00
$90.00
$212.00
24
(2)

May modify histone acetylation, potentially affecting the transcription of EBF2.